12-year-old boy facing long battle with leukemia hopes to return to school in june | Inquirer News

12-year-old boy facing long battle with leukemia hopes to return to school in june

Miguel Ivan Mendoza

Although Miguel Ivan Mendoza will be under treatment for acute lymphoblastic leukemia until 2020, doctors have given him permission to go back to school.

This June, the 12-year-old boy will be in the fourth grade at Sinillian First Elementary School in Camiling, Tarlac. He was diagnosed with the disease in July 2014.

Article continues after this advertisement

“They told us that he might get bored at home if he does not enroll this June. If ever, he will go to school once a week. The rest of the lessons will be given as homework,” Miguel Ivan’s mother, Jeuanie, said.

FEATURED STORIES

Miguel Ivan is scheduled to return to Philippine Children’s Medical Center next week for a checkup in preparation for the third of his 12-cycle chemotherapy treatment. The sessions are done three months apart.

“I hope you can help us raise funds to extend his life. We need to spend P50,000 per chemotherapy session. I am appealing to kindhearted readers. May God bless you more,” said Jeuanie. Her husband, Allan, receives P95 a day as a carwash boy.

Article continues after this advertisement

Jeuanie Mendoza can be reached at 0997-4398778. Donations can be deposited in the Union Bank account of her husband, Allan Mendoza (109451167790), for their son’s medical expenses.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.